Form 4: Intensity Therapeutics CFO Acquires Shares Through Employee Stock Purchase Plan

Intensity Therapeutics' Chief Financial Officer, Joseph Talamo, acquired 14,179 shares of common stock at $0.261 per share through the company's Employee Stock Purchase Plan.

Summary

• Joseph Talamo, Chief Financial Officer of Intensity Therapeutics, Inc. (INTS), acquired 14,179 shares of common stock.
• The transaction occurred on June 30, 2025.
• Shares were purchased at a price of $0.261 per share.
• The acquisition was made under the Issuer's 2024 Employee Stock Purchase Plan (ESPP).
• The purchase price represents 85% of the closing price of the common stock on June 30, 2025, as per the ESPP terms.
• Following this transaction, Joseph Talamo directly beneficially owns 14,179 shares.
• The transaction is exempt under SEC Rules 16b-3(c) and 16b-3(d).

Sentiment

Score: 7

Explanation: The acquisition of shares by a Chief Financial Officer, even through an ESPP, generally signals a positive alignment of interests and confidence in the company's prospects. While not a large open-market purchase, it's a routine positive.

Positives

• Insider acquisition of shares, indicating management confidence in the company's future.
• Participation in the Employee Stock Purchase Plan (ESPP) suggests alignment of employee interests with shareholder interests.

Future Outlook

NA

Industry Context

This Form 4 filing reflects a routine insider transaction, specifically an acquisition of shares by a Chief Financial Officer through an Employee Stock Purchase Plan. Such transactions are common across industries and typically indicate an executive's participation in company-sponsored equity programs, aligning their financial interests with the company's performance.

Related Party Transactions

• Joseph Talamo, as CFO, acquired shares from Intensity Therapeutics through the company's 2024 Employee Stock Purchase Plan, which is a standard related-party transaction for employee equity programs.

Stakeholder Impact

• Shareholders: The acquisition by a key executive may be viewed positively, signaling confidence in the company's future performance and aligning management's interests with shareholders.
• Employees: The transaction highlights the existence and utilization of an Employee Stock Purchase Plan, which can be a benefit for employees to acquire company stock at a discount.

Key Dates

Recommendation

Keywords

Intensity Therapeutics, INTS, Joseph Talamo, CFO, SEC Form 4, Insider Trading, Stock Acquisition, Employee Stock Purchase Plan, ESPP, Common Stock